Quan Venture Fund II, L.P. 3
3 · NextCure, Inc. · Filed May 8, 2019
Insider Transaction Report
Form 3
NextCure, Inc.NXTC
Xu Stella
Director
Holdings
- (indirect: By Quan Venture Fund II, L.P.)
Series B-2 Preferred Stock
→ Common Stock (978,570 underlying)
Footnotes (2)
- [F1]The reported securities are convertible into shares of Common Stock on a 1-for-8.0338 basis at the holder's election, will automatically convert into shares of Common Stock upon the closing of the Issuer's initial public offering, and have no expiration date.
- [F2]The general partner of Quan Venture Fund II, L.P. is Quan Venture Partners II, L.L.C. Stella Xu is a managing director of Quan Venture Partners II, L.L.C. and shares the ultimate power to vote or dispose of the shares held by Quan Venture Fund II, L.P. Dr. Xu disclaims beneficial ownership of the shares held by Quan Venture Fund II, L.P., except to the extent of her pecuniary interest.